Cellebrite DI Ltd.
Cellebrite DI Ltd.（CLBT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
clbt · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$23.00
Consensus
$19.75
+48.8% upside
Low
$15.00
Median: $20.5 · Last Close: $13.28
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.75
48.8% upside
High Target
$23
73.3%
Low Target
$15
13.0%
Current Price
$13.28
as of today
Based on analyst price targets, the CLBT stock price prediction for the next 12 months ranges from $15 to $23. The consensus CLBT price forecast of $19.75 implies 48.8% upside from the current price of $13.28.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.67 | ↑ 2.97% |
1-day model range: $13.57–$13.77. Peak: $13.77 (+2.97%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $17 | +26.2% |
| 2028 | $19 | +45.9% |
| 2029 | $21 | +59.7% |
| 2030 | $22 | +68.7% |
| 2031 | — | +74.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLBT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Needham | Maintains | Buy→Buy |
| 2026-02-12 | Needham | Maintains | Buy→Buy |
| 2025-11-13 | Lake Street | Maintains | Buy→Buy |
| 2025-11-13 | Needham | Maintains | Buy→Buy |
| 2025-11-13 | B of A Securities | Maintains | Buy→Buy |
| 2025-11-13 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-09-24 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-08-15 | Lake Street | Maintains | Buy→Buy |
| 2025-08-14 | Needham | Maintains | Buy→Buy |
| 2025-06-23 | JP Morgan | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cellebrite DI Ltd. (CLBT) stock. Of the recent 42 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover CLBT.
分析师推荐趋势
CLBT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$473M
↓ 29.1% YoY
Revenue Next Year
$568M
↑ 20.1% YoY
EPS This Year
$0.33
EPS Next Year
$0.33
↓ 0.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLBT EPS of $0.33 for the current fiscal year, based on estimates from 5 analysts. The CLBT revenue forecast is $473M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CLBT 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CLBT 的共识目标价为 $19.75（+48.8% 上行空间），分析师共识为 Buy。
CLBT 的短期预测（明日）为 $13.67（+2.97%）。 CLBT 对 2027 年的股价预测均值为 $17。 CLBT 对 2030 年的预测区间为 $21–$24。
Cellebrite DI Ltd. 在 NASDAQ 上市，代码 CLBT。CLBT 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CLBT 预测 · 8 个问题根据 8 位华尔街分析师，CLBT 的 12 个月平均目标价为 $19.75，最高 $23.00、最低 $15.00。若有图表，中位目标价可在上方查看。相对当前价 $13.28，隐含约 +48.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.